2019
DOI: 10.1016/j.yclnex.2019.09.004
|View full text |Cite
|
Sign up to set email alerts
|

Ketogenic diet treatment in adults with glycogenosis type IIIa (Morbus Cori)

Abstract: s u m m a r yBackground: Glycogen storage disease type IIIa (GSDIIIa) is a defect of the debranching enzyme (amylo-1,6-glucosidase) in glycogenolysis and has an effect on the muscles and the liver. The guidelines for diagnosis and management of GSDIIIa primarily recommend a nutritional therapy to avoid hypoglycaemia. For adolescents and adults, the recommendation is a diet high in protein (25 E%) and moderate or low in carbohydrates (<50 E%) while avoiding simple sugars and fasting. There are some indications … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 19 publications
(19 reference statements)
0
1
0
1
Order By: Relevance
“…However, eucaloric KD improves energy balance by increasing the blood levels of ketone bodies, which are alternative substrates for energy production in the brain, heart, and skeletal muscles (10). In addition to conventional treatment, novel nutritional therapies, including CKD, MAD, high-fat diet, and synthetic ketone bodies, applied to maintain normoglycemia and improve long-term complications such as cardiomyopathy (CMP) have been reported in recent studies (12)(13)(14)(15).…”
Section: Glycogen Storage Disease Type IIImentioning
confidence: 99%
“…However, eucaloric KD improves energy balance by increasing the blood levels of ketone bodies, which are alternative substrates for energy production in the brain, heart, and skeletal muscles (10). In addition to conventional treatment, novel nutritional therapies, including CKD, MAD, high-fat diet, and synthetic ketone bodies, applied to maintain normoglycemia and improve long-term complications such as cardiomyopathy (CMP) have been reported in recent studies (12)(13)(14)(15).…”
Section: Glycogen Storage Disease Type IIImentioning
confidence: 99%
“…El diagnóstico definitivo se basa en demostrar la deficiencia enzimática (5), el tratamiento incluye dieta alta en proteínas con suplementos de maicena (6). No existe cura, las recomendaciones están basadas en el seguimiento de síntomas y el tratamiento dietético, cuyo cumplimiento refleja resultados positivos evidenciados en normoglicemia (7).…”
Section: Introductionunclassified